CAS No. |
11011-38-4 |
中文名称 |
8-乙基-5,19-二羟基-3-(1-(4-羟基-3-甲氧基环己基)丙-1-烯-2-基)-14,16-二甲氧基-4,10,12,18-四甲基-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-十六氢-3H-15,19-环氧吡啶并[2,1-c][1]氧杂[4]氮杂环二十三烯-1,7,20,21(4H,23H)-四酮 |
英文名称 |
8-ethyl-5,19-dihydroxy-3-(1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
别名 |
ASCOMYCIN, STREPTOMYCES HYGROSCOPICUS;ASCOMYCIN, STREPTOMYCES HYGROSCOPICUS VAR ASCOMYCETICUS;FR-900520;FK-520;IMMUNOMYCIN;AAG;ASCOMYCIN (IMMUNOMYCIN, FR-900520) \ INH IBITS CALCINEURIN (PP2B);(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-8-Ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone |
标准英文名 |
8-ethyl-5,19-dihydroxy-3-(1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
MDL No. |
MFCD06198665 |
分子式 |
C43H69NO12 |
分子量 |
792.02
|
精确分子量 |
791.48
|
SMILES |
CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(O)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC |
标准SMILES |
CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)C(O)CC1=O)C(C)=CC1CC(OC)C(O)CC1 |
用途 |
Ascomycin is used in the treatment of autoimmune diseases such as atopic dermatitis, allergic contact dermatitis, psoriasis, lupus erythematosus, lichen planus, vitiligo, Netherton syndrome, and graft-versus-host disease (GVHD). |
InChIKey |
ZDQSOHOQTUFQEM-UHFFFAOYSA-N |